M
Malcolm Law
Researcher at Queen Mary University of London
Publications - 104
Citations - 19941
Malcolm Law is an academic researcher from Queen Mary University of London. The author has contributed to research in topics: Blood pressure & Population. The author has an hindex of 42, co-authored 103 publications receiving 18908 citations. Previous affiliations of Malcolm Law include St Bartholomew's Hospital.
Papers
More filters
Journal ArticleDOI
Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies
TL;DR: All the classes of blood pressure lowering drugs have a similar effect in reducing CHD events and stroke for a given reduction in blood pressure, indicating that the benefit is explained by blood pressure reduction itself.
Journal ArticleDOI
Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis
TL;DR: Whether the association of serum homocysteine concentration with ischaemic heart disease, deep vein thrombosis and pulmonary embolism, and stroke is causal and, if so, to quantify the effect of homocy Steine reduction in preventing them, there is strong evidence that the association between homocy steine and cardiovascular disease is causal.
Journal ArticleDOI
Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis.
TL;DR: Statins can lower LDL cholesterol concentration by an average of 1.8 mmol/l which reduces the risk of IHD events by about 60% and stroke by 17% and is corroborated by results from the nine cohort studies.
Journal ArticleDOI
A strategy to reduce cardiovascular disease by more than 80
Nicholas J. Wald,Malcolm Law +1 more
TL;DR: In this paper, the combination of drugs and vitamins, and their doses, for use in a single daily pill to achieve a large effect in preventing cardiovascular disease with minimal adverse effects was proposed.
Journal ArticleDOI
Interpretation of the evidence for the efficacy and safety of statin therapy.
Rory Collins,Christina Reith,Jonathan Emberson,Jane Armitage,Colin Baigent,Lisa Blackwell,Roger S. Blumenthal,John Danesh,George Davey Smith,David L. DeMets,Stephen J. W. Evans,Malcolm Law,Stephen MacMahon,Seth S. Martin,Bruce Neal,Neil R Poulter,David Preiss,Paul M. Ridker,Ian Roberts,Anthony Rodgers,Peter Sandercock,Kenneth F. Schulz,Peter S. Sever,John Simes,Liam Smeeth,Nicholas J. Wald,Salim Yusuf,Richard Peto +27 more
TL;DR: The large-scale evidence from randomised trials indicates that it is unlikely that large absolute excesses in other serious adverse events still await discovery, and any further findings that emerge about the effects of statin therapy would not be expected to alter materially the balance of benefits and harms.